Australia & New Zealand's Preeminent Biologics Conference

24 - 25 February 2027 Melbourne, Australia
Register Now Post-Event Report

About the Event

Excellence in Biologics Manufacturing, Cell and Gene Therapy, and RNA Therapeutics for Australia & New Zealand's Future Biologics Industry.

With a biotechnology sector benchmarked for global excellence due to world-class facilities, researchers, and regulation, the ANZ region has a promising future for biologics innovation and manufacturing. The path ahead will require a focus on further commercial translation of research, and as such, partnerships and collaborations will be critical. Expanding sovereign manufacturing in Australia & New Zealand will also play a massive role in uplifting the sector in the region.

The 5th annual ANZ Biologics Festival 2027 is the region's premier conference that aims to gather the innovators, pioneers, and leaders in the biologics fraternity, including Biologics, Biosimilars, Vaccines, Cell and Gene Therapy (CGT), and RNA Therapeutics, to showcase the latest from ideation to commercialization phase and beyond. It provides the right environment to meet the entire biopharma fraternity under one roof.

Join us to bring investment to Australia & New Zealand's bio sector and explore a wealth of opportunities in biologics innovation, expanding the region's manufacturing footprint, and advancing cell and gene therapy and RNA therapeutics. The 2027 festival will feature dedicated tracks on Biologics Manufacturing, Cell and Gene Therapy, and RNA Therapeutics, offering a comprehensive view of the latest advancements and challenges in these critical areas.

What we'll cover

Key Themes

R&D Innovation & Antibody Engineering
Explore the latest in biologics R&D — from monoclonal and bispecific antibodies to fusion proteins and next-gen treatments transforming biopharma innovation.
Manufacturing Excellence & Scalability
Learn how single-use systems, digital tools, and scalable processes are driving higher efficiency, flexibility, and quality across biologics manufacturing.
Clinical Trials & Regulatory Insights
Gain practical insights into early-phase clinical trials in ANZ, adaptive trial designs, faster regulatory pathways and alignment with global standards.
Supply Chain Optimisation
Discover strategies in cold chain logistics, smart packaging, and real-time temperature monitoring to strengthen biologics delivery networks.
Analytical & Quality Control Technologies
Understand the latest tools for biologics production — from GMP testing and automated quality checks to advanced analytics and comparability studies.
AI, Automation & Digital Transformation
See how AI, digital twins, and smart automation are reshaping biologics operations through predictive maintenance and process optimisation
BY THE NUMBERS

Our Impact in Asia's Biopharma

300+
Attendees

Connect with 300+ industry professionals from across ANZ and Asia to exchange ideas and build lasting collaborations.

120+
Companies

Meet over 120 leading biopharma, biotech, and research organisations driving innovation in the biologics sector.

50+
Speakers

Hear from 50+ experts and thought leaders sharing cutting-edge science, practical case studies, and commercial insights.

TESTIMONIALS

Hear from past attendees and industry leaders

 "The ANZ Biologics Festival is always a great mix of academia and industry and provides a thoughtfully curated program of interesting talks across a diverse range of topics." 
Senior Manager, Development, ACAMI
La Trobe University
 "If you are part of the biotech or supplier community developing novel therapeutics in Australia this event is definitely worth considering. Congratulations to the organisers. I hope and expect to see this event continue to grow and mature over time." 
Non-Executive Director
FacioBiotherapies
 "Excellent conference to understand the Australian dynamic and Eco System on Biologic research and manufacturing." 
Head of Global Clinical Manufacturing, mRNA CoE
Sanofi
 "The highlight of this event was the arrangement of the 1:1 meetings. Even if attendees showed interest during the presentations, there is always a chance they might not visit the booth afterward. By being able to pre-arrange meetings with targeted participants in advance, we were able to engage in much more efficient and focused networking."
Business Development Director
Pfanstiehl
 "It was a pleasure to attend and speak at the ANZ Biologic Festival, and I was impressed by the seamless organization and excellent arrangements. The event created a dynamic environment for networking and exchanging ideas with like-minded peers in the Australian Biopharma sector, offering outstanding networking opportunities. It was a truly rewarding and professionally valuable experience." 
TheiaNova

Sponsors & Media Partners

Special thanks to our event partners, without whom we would not be able to provide this networking, learning, and collaborating platform.

Silver Sponsor
Pfanstiehl-hd
Exhibitors
WuXi Biologics
Truking logo 1
ProBio Logo-Grey 1

2027 SPEAKERS

Peter Tobin_TelixPharma
Dr. Peter Tobin
VP Head of Translational Medicine
Telix Pharmaceutical
Australia flag Australia
JaseBrouwer_headshot
Dr. Jase Brouwer
CSO & Co-founder
Proxima Bio
Australia flag Australia

Agenda At A Glance

CONFERENCE DAY 1 | 24th February 2027, Wednesday
ANZ Biologics & Next-Gen Therapeutics Forum CGT FORUM
Leadership Panel Discussion
Australia's Position in the Global Advanced Therapeutics Landscape
Morning Tea, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Clinical Trials Innovation & Translational Medicine
Clinical Translation of Cell & Gene Therapies
 From Preclinical Development to First-in-Human Studies 
Lunch, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Advanced Bioprocessing & Manufacturing for Next-Gen Therapeutics
CGT Manufacturing & CMC Development
 Scale-Up, Tech Transfer & Commercial Readiness  
Afternoon Tea, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
ADCs, Bispecific Antibodies & Emerging Biologic Modalities
Next-Generation Cell & Gene Therapies
 Advancing CAR-T, NK Cell Platforms, Gene Editing and Advanced Delivery Technologies
End of Conference Day 1
Awards 2027
CONFERENCE DAY 2 | 25th February 2027, Thursday
ANZ Biologics & Next-Gen Therapeutics Forum RNA FORUM
GMP Manufacturing, Quality Control & Regulatory Readiness
Scalable RNA Manufacturing
 Process Development, Platform Technologies & Production Strategies 
Morning Tea, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
AI, Digitalization & Data-Driven Biologics Development
RNA Delivery Technologies & Targeted Delivery Systems
Lunch, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
ANZ Emerging Biopharma Showcase
Next-Generation RNA Therapeutics
Oligonucleotides, Circular RNA & Precision Medicines
Afternoon Tea, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Supply-Chain Management & Temperature Controlled Logistics
Regulatory Pathways, Policy Perspectives & Quality Standards for RNA Therapeutics
End of Conference
CONFERENCE AGENDA

Day 1

Wednesday, 24 February 2027

ANZ Biologics & Next-Gen Therapeutics Forum
CGT FORUM
8:50
IMAPAC Opening Address
8:55
Chairman’s Welcome Address
Leadership Panel Discussion: Australia’s Role in Shaping the Future of the Global Advanced Therapeutics Landscape
9:00
Leadership Panel Discussion: Australia’s Role in Shaping the Future of the Global Advanced Therapeutics Landscape
  • How can Australia strengthen its position as a global hub for advanced therapeutics innovation, clinical translation, and manufacturing?
  • What ecosystem capabilities are needed to accelerate cell and gene therapy development, commercialisation, and patient access?
  • How can industry, academia, government, and investors collaborate to build a sustainable advanced therapeutics ecosystem?
9:45
Enabling the Future of Advanced Therapies: Innovative Technologies for Scalable Cell & Gene Therapy Manufacturing
  • Advancing next-generation manufacturing platforms to improve scalability, consistency, and cost efficiency
  • Supporting automation, digitalisation, and closed-system solutions for advanced therapy production
  • Addressing key challenges in process development, quality control, and commercial-scale manufacturing
Reserved for Solution Provider
10:00
Accelerating Advanced Therapeutics from Discovery to Patient Impact: Real-World Strategies for Clinical Translation
  • Overcoming challenges in translating advanced therapies from research breakthroughs into clinical applications
  • Optimising clinical development pathways, regulatory strategies, and patient access models
  • Building partnerships across academia, biotech, and healthcare systems to accelerate innovation
10:25
Morning Tea, Exhibition Viewing & 1-1 Attendee Networking
Clinical Trials Innovation & Translational Medicine
Clinical Translation of Cell & Gene Therapies: From Preclinical Development to First-in-Human Studies
11:10
Positioning Australia & New Zealand as a Global Hub for Early-Phase Clinical Trials
  • Competitive advantages of the ANZ clinical trial ecosystem
  • Regulatory pathways enabling faster trial initiation
  • Attracting international investment and partnerships
  • Building globally competitive translational research capabilities
11:10
Clinical Translation of Cell & Gene Therapies: From Preclinical Development to First-in-Human Studies
  • Navigating the transition from preclinical research to clinical trials: key scientific, regulatory, and operational considerations
  • Optimising trial design, patient selection, and manufacturing readiness for first-in-human studies
  • Overcoming challenges in safety assessment, scalability, and accelerating pathways towards clinical success
11:35
Maximising Clinical Success: Strategies to Reduce Risk, Cost & Time to Market
  • Improving clinical trial productivity
  • Innovative partnership models between biotech, CROs and academia
  • Balancing speed with quality and compliance
  • Preparing biologics for successful commercialisation
Reserved for Solution Provider
11:35
Enabling Clinical Translation: Advanced Platforms and Technologies for Accelerating Cell & Gene Therapy Development
  • Supporting seamless transition from research-grade to clinical-grade manufacturing through innovative solutions
  • Improving process optimisation, analytical capabilities, and quality control for advanced therapies
  • Leveraging automation and digital technologies to enhance reproducibility and scalability
Reserved for Solution Provider
11:50
Accelerating Translation: Bridging Discovery to Commercial Success in Biologics
  • Closing the gap between laboratory discovery and first-in-human studies
  • Strategies to de-risk biologics development and improve clinical success rates
  • Strengthening industry-academia collaboration for faster translation
  • Building sustainable commercial pathways for innovative therapeutics
11:50
Advancing Cell & Gene Therapy Trials: Building Sustainable Pathways from Innovation to Patient Access
  • Addressing regulatory, clinical, and operational barriers in bringing advanced therapies to patients
  • Strengthening collaboration between developers, clinical sites, regulators, and healthcare providers
  • Creating sustainable models for broader adoption and commercialisation of cell and gene therapies
12:15
Lunch, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Advanced Bioprocessing & Manufacturing for Next-Gen Therapeutics
CGT Manufacturing & CMC Development: Scale-Up, Tech Transfer & Commercial Readiness
1:30
Manufacturing Complex Biologics: Overcoming Process Development & Scale-Up Challenges
  • Manufacturing monoclonal antibodies, ADCs and fusion proteins
  • Process robustness and product consistency
  • Improving yield, productivity and quality attributes
  • Technology innovations supporting complex biologics
1:30
CGT Manufacturing & CMC Development: Scale-Up, Tech Transfer & Commercial Readiness
  • Building robust CMC strategies to support the transition from early development to commercial manufacturing
  • Managing scale-up challenges, technology transfer, and process consistency across manufacturing sites
  • Preparing cell and gene therapies for regulatory approval and commercial launch
1:55
Manufacturing Innovation for Complex Biologics: Driving Productivity, Quality & Speed
  • Advanced manufacturing platforms for complex biologics
  • Process intensification and continuous bioprocessing
  • Improving product quality and manufacturing consistency
  • Reducing development timelines through innovation
Reserved for Solution Provider
1:55
Accelerating CGT Manufacturing Success: Advanced Technologies for Scalable and Flexible Production
  • Enabling scalable manufacturing through innovative platforms, automation, and process optimisation
  • Supporting efficient technology transfer and global manufacturing alignment
  • Improving quality, cost efficiency, and operational flexibility for commercial-scale CGT production
Reserved for Solution Provider
2:10
Accelerating CMC Development for Next-Generation Therapeutics
  • Integrating CMC early in product development
  • Analytical strategies for complex biologics
  • Manufacturing readiness for regulatory submissions
  • Accelerating timelines without compromising quality
2:10
Building Commercial-Ready Cell & Gene Therapy Manufacturing Ecosystems
  • Developing sustainable manufacturing models to meet growing demand for advanced therapies
  • Strengthening partnerships across biotech, CDMOs, and technology providers to accelerate market readiness
  • Addressing regulatory, supply chain, and operational considerations for long-term commercial success
2:35
Smart Bioprocessing: Leveraging AI, Automation & Digital Twins for Manufacturing Excellence
  • AI-driven process monitoring and optimisation
  • Digital twins for predictive manufacturing
  • Advanced analytics and real-time quality control
  • Data-driven decision making across manufacturing operations
2:35
From Clinical Success to Commercial Reality: Scaling Cell & Gene Therapies for Global Patient Access
  • Lessons learned from transitioning advanced therapies into commercial manufacturing
  • Balancing speed, quality, cost, and regulatory expectations during scale-up
  • Creating resilient ecosystems to support global distribution and patient access
3:00
Afternoon Tea, Exhibition Viewing & 1-1 Attendee Networking
ADCs, Bispecific Antibodies & Emerging Biologic Modalities
Next-Generation Cell & Gene Therapies: Advancing CAR-T, NK Cell Platforms, Gene Editing and Advanced Delivery Technologies
3:40
Cell-Surface Degraders: Reprogramming Protein Turnover for Autoimmune Disease
  • Harnessing cell-surface E3 ligases to selectively degrade disease-driving immune receptors
  • Achieving deeper, more durable and cell-selective target suppression beyond conventional antibody blockade
  • Expanding the druggable target space and therapeutic window for challenging cell-surface targets
Dr. Jase Brouwer
CSO & Co-founder, Proxima Bio, Australia
3:40
Next-Generation Cell & Gene Therapies: Advancing CAR-T, NK Cell Platforms, Gene Editing and Advanced Delivery Technologies
  • Exploring the evolution of next-generation cell and gene therapy platforms, including CAR-T, TCR-T, NK cell therapies, and allogeneic approaches
  • Advancing gene editing technologies and delivery systems to improve therapeutic precision, safety, and efficacy
  • Overcoming scientific and manufacturing challenges to accelerate the development of next-generation therapies
4:05
Manufacturing Complex Biologics: Scaling ADCs & Bispecific Antibodies for Global Markets
  • Process development and analytical strategies
  • Manufacturing highly potent biologics 
  • Quality control and regulatory expectations 
  • Scaling production while maintaining consistency
4:05
Enabling Next-Generation Cell & Gene Therapies: Innovations in Gene Editing, Delivery Systems and Manufacturing Platforms
  • Supporting advanced therapy development through innovative vector technologies, delivery platforms, and manufacturing solutions
  • Improving scalability, process control, and quality attributes for emerging cell and gene therapy modalities
  • Accelerating translation from research breakthroughs to clinical and commercial applications
Reserved for Solution Provider
4:20
Panel Discussion: The Next Wave of Targeted Biologic Innovation – Advancing ADCs, Bispecific Antibodies & Emerging Therapeutic Modalities
  • Which next-generation biologic modalities are poised to transform the future of precision medicine?
  • Advancing ADCs, bispecific antibodies, multispecifics, radiopharmaceuticals and other emerging biologics from discovery to clinical success.
  • Overcoming development, manufacturing and regulatory challenges to accelerate commercialisation.
  • Strengthening collaboration across biotech, pharma, academia and investors to drive the next generation of biologic innovation.
4:20
The Future of Cell & Gene Therapy: Building Scalable Platforms for Broader Patient Access
  • Evaluating the potential of next-generation modalities to address limitations of current cell therapies
  • Developing strategies for scalable manufacturing, regulatory alignment, and global deployment
  • Building collaborative ecosystems to advance innovation and expand patient access
4:45
Shaping the Future of Advanced Therapies: From Scientific Breakthroughs to Real-World Impact
  • Identifying the next wave of innovations transforming the advanced therapeutics landscape
  • Balancing innovation, affordability, and accessibility in future therapy development
  • Strengthening partnerships across industry, academia, and healthcare systems
5:15
End of Conference Day 1
5:10
End of Conference Day 1
6:00
Awards 2027
CONFERENCE AGENDA

Day 2

Thursday, 25 February 2027

ANZ Biologics & Next-Gen Therapeutics Forum
RNA FORUM
8:50
IMAPAC Opening Address
8:50
IMAPAC Opening Address
8:55
Chairman’s Welcome Address
8:55
Chairman’s Welcome Address
GMP Manufacturing, Quality Control & Regulatory Readiness
Scalable RNA Manufacturing: Process Development, Platform Technologies & Production Strategies
9:00
Future-Ready GMP: Advancing Manufacturing, Quality & Regulatory Excellence for Next-Generation Therapeutics
  • Evolving GMP expectations for biologics and ADC therapeutics
  • Modernising quality systems through digitalisation and automation
  • Inspection readiness and maintaining global regulatory compliance
  • Building future-ready manufacturing organisations
9:00
Panel Discussion: Scaling RNA Manufacturing: Building the Future of RNA Therapeutics Production
  • How can the industry overcome key challenges in scaling RNA manufacturing from clinical development to commercial production?
  • What capabilities, technologies, and partnerships are needed to build resilient RNA manufacturing ecosystems?
  • How can companies balance innovation, cost efficiency, quality requirements, and regulatory expectations in RNA production?
9:25
Next-Generation Quality Control: Leveraging Advanced Analytics for Faster Product Release
  • Rapid microbiological methods and real-time testing
  • PAT and advanced analytical technologies
  • AI-enabled quality control and release testing
  • Reducing release timelines while ensuring compliance
Reserved for Solution Provider
9:45
Enabling Scalable RNA Production: Innovative Platforms for Efficient Manufacturing and Process Optimisation
  • Leveraging advanced technologies to improve RNA production efficiency, yield, and reproducibility
  • Supporting flexible manufacturing approaches through automation, modular platforms, and process optimisation
  • Enhancing analytical capabilities and quality control strategies for next-generation RNA products
Reserved for Solution Provider
9:45
Panel Discussion: Future-Ready GMP Strengthening Manufacturing, Quality & Regulatory Excellence for Next-Generation Therapeutics
  • How are GMP expectations evolving for biologics, RNA therapeutics, and advanced therapies?
  • Balancing innovation, speed, and regulatory compliance.
  • Digital transformation and AI in quality management systems.
  • Building resilient manufacturing operations for global commercialisation.
10:00
Advancing RNA Therapeutics from Development to Commercial Manufacturing: Real-World Strategies and Challenges
  • Navigating process development, technology transfer, and scale-up challenges for RNA-based therapies
  • Strengthening manufacturing readiness and supply chain strategies for clinical and commercial success
  • Building collaborations across biotech, CDMOs, and technology providers to accelerate RNA therapeutic innovation
10:25
Morning Tea, Exhibition Viewing & 1-1 Attendee Networking
AI, Digitalization & Data-Driven Biologics Development
RNA Delivery Technologies & Targeted Delivery Systems
11:10
Harnessing AI, Bioinformatics & Digital Technologies to Accelerate Next-Generation Biologics Development
  • AI and computational biology accelerating biologics discovery and optimisation
  • Bioinformatics and multi-omics enabling precision therapeutic development
  • Digital transformation across CMC, manufacturing and quality operations
  • Building integrated, data-driven biologics development ecosystems
11:10
RNA Delivery Technologies & Targeted Delivery Systems: Advancing Precision Therapeutics
  • Exploring emerging delivery platforms including lipid nanoparticles, viral and non-viral systems for RNA therapeutics
  • Improving targeting, stability, safety, and efficacy of RNA delivery approaches
  • Translating innovative delivery technologies into clinically viable RNA-based therapies
11:35
From Data to Discovery: AI, Bioinformatics & Computational Biology in Next-Generation Therapeutics
  • Leveraging AI, genomics, proteomics and bioinformatics to accelerate biologics and therapeutic discovery.
  • Harnessing computational biology and multi-omics to advance biomarker discovery, precision medicine and translational research.
  • Integrating AI-driven analytics and digital technologies to improve clinical decision-making and drug development.
  • Building data-driven strategies that accelerate innovation, optimise R&D, and support successful clinical and commercial outcomes.
Reserved for Solution Provider
11:35
Next-Generation RNA Delivery Platforms: Enabling Efficient and Targeted Therapeutic Delivery
  • Advancing delivery technologies to improve biodistribution, cellular uptake, and therapeutic performance.
  • Developing scalable and robust delivery platforms for diverse RNA modalities.
  • Supporting faster development timelines through innovative formulation and analytical solutions
Reserved for Solution Provider
11:50
From Algorithms to Impact: Scaling AI Across the Biologics Value Chain
  • Embedding AI across R&D, CMC, manufacturing and regulatory functions
  • Building connected digital ecosystems for end-to-end biologics development
  • Overcoming data integration, governance and interoperability challenges
  • Measuring business value and accelerating organisational adoption
11:50
Overcoming RNA Delivery Challenges: From Research Innovation to Clinical Translation
  • Addressing key barriers in RNA delivery including immunogenicity, targeting precision, and manufacturing complexity
  • Optimising delivery strategies for different therapeutic applications and patient populations
  • Building partnerships to accelerate RNA therapeutics from discovery to clinical success
12:15
Lunch, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
ANZ Emerging Biopharma Showcase
Next-Generation RNA Therapeutics: Oligonucleotides, Circular RNA & Precision Medicines
1:30
Innovators to Watch: Showcasing Australia's & New Zealand's Next Generation of Biopharma Leaders
  • Breakthrough biologics and therapeutic innovations from emerging biopharma
  • Translating cutting-edge science into clinical and commercial success
  • Emerging technologies addressing unmet medical needs
  • Building partnerships to accelerate global growth
1:30
Next-Generation RNA Therapeutics: Advancing Oligonucleotides, Circular RNA and Precision Medicines
  • Exploring the potential of emerging RNA modalities, including oligonucleotides and circular RNA, in transforming precision medicine
  • Addressing development challenges across discovery, delivery, manufacturing, and clinical translation
  • Building strategies to accelerate next-generation RNA therapeutics from innovation to patient impact
1:55
Emerging Biopharma Spotlight: Accelerating Innovation from Discovery to Commercialisation
  • Translational science driving next-generation therapeutics
  • Overcoming funding and development challenges
  • Building scalable and investment-ready companies
  • Partnering with global biopharma for market expansion
Reserved for Solution Provider
1:55
Technologies for Development, Manufacturing and Delivery
  • Supporting RNA therapeutic development through innovative platforms, analytical tools, and manufacturing solutions
  • Improving scalability, quality control, and production efficiency for emerging RNA modalities
  • Accelerating translation of RNA innovations through integrated technology solutions and partnerships
Reserved for Solution Provider
2:10
Panel Discussion: Scaling ANZ Biopharma Innovation from Startup to Global Success
  • What does it take to build a globally competitive biotech?
  • Accessing capital, partnerships and manufacturing capabilities
  • Navigating clinical development and regulatory pathways
  • Positioning ANZ innovation on the global stage
2:10
From Discovery to Precision Medicine: Unlocking the Clinical Potential of Advanced RNA Platforms
  • Advancing oligonucleotide and circular RNA therapies through improved design, targeting, and therapeutic performance
  • Navigating regulatory pathways and clinical development strategies for novel RNA medicines
  • Establishing sustainable ecosystems to support commercialisation and broader patient access
2:35
The Future of RNA Medicine: Transforming Breakthrough Science into Real-World Therapeutic Solutions
  • Identifying the next wave of RNA innovations shaping the future of healthcare
  • Balancing scientific advancement with manufacturing, regulatory, and commercial considerations
  • Strengthening collaborations across biotech, academia, and industry to accelerate RNA medicine adoption
3:00
Afternoon Tea, Exhibition Viewing & 1-1 Attendee Networking
Supply-Chain Management & Temperature Controlled Logistics
Regulatory Pathways, Clinical Translation & Commercialisation of RNA Therapeutics
3:40
Delivering Complex Biologics: Overcoming Supply Chain & Temperature-Controlled Logistics Challenges
  • Logistics strategies for ADCs and advanced biologics
  • Managing ultra-low temperature storage and transportation
  • Ensuring product integrity across global supply networks
  • Risk mitigation and contingency planning
3:40
Regulatory Pathways, Clinical Translation & Commercialisation of RNA Therapeutics
  • Navigating evolving regulatory frameworks for RNA therapeutics and accelerating pathways from clinical development to approval
  • Addressing key challenges in clinical translation, manufacturing readiness, and long-term safety monitoring
  • Building sustainable strategies for commercialisation, market access, and global adoption of RNA medicines
4:05
Future-Proofing Biologics Supply Chains: From Cold Chain Excellence to Digital Logistics
  • Next-generation cold chain technologies for biologics 
  • AI-enabled forecasting and inventory optimisation
  • Building resilient global distribution networks
  • Sustainability and carbon reduction across the supply chain
4:05
Accelerating RNA Therapeutics Development: Regulatory, Analytical and Manufacturing Solutions for Clinical Success
  • Supporting regulatory submissions through advanced analytical platforms, quality strategies, and development solutions
  • Enabling efficient clinical translation through improved process characterisation and manufacturing readiness
  • Helping organisations overcome regulatory and operational barriers from early development to commercial launch
4:30
Smart Supply Chains for Next-Generation Therapeutics
  • AI and predictive analytics transforming supply chain operations
  • Real-time monitoring through IoT and smart packaging
  • Digital supply chain visibility and traceability
  • Building agile supply networks for future therapeutics
4:30
From Clinical Breakthroughs to Market Access: Real-World Strategies for Commercialising RNA Therapeutics
  • Translating promising RNA technologies into clinically validated and commercially viable therapies
  • Optimising clinical development strategies, regulatory engagement, and market access planning
  • Establishing partnerships and business models to accelerate patient access to RNA medicines
4:55
Chairman’s Closing Remarks
4:55
Chairman’s Closing Remarks
5:00
End of Conference
5:00
End of Conference
Register Now
By Profile
Big Pharma
37%
Australia Biopharma
26%
CMOs & CDMOs
15%
CROs
9%
Technology & Service Providers
9%
Investors, Government, Others
4%
By Job Title
C-Level Executives
12%
VPs, Directors, Heads of Process Development, Manufacturing & Bioprocessing/MSAT
33%
VPs, Directors, Heads of Clinical Trials & Development & R&D
19%
Head of Quality Assurance, Control and Analytics
13%
Supply Chain & Logistics Leaders
10%
Business Development & Marketing Professionals
13%
By Geography
Map
22%
APAC (excl. ANZ)
11%
Rest of The World
11%
Perth/Western Australia
11%
Rest of Australia
23%
New Zealand
22%
Sydney/Melbourne
22%
APAC (excl. ANZ)
11%
Rest of The World
11%
Perth/Western Australia
11%
Rest of Australia
23%
New Zealand
22%
Sydney/Melbourne

Who Should Sponsor?

BIOMANUFACTURING SOFTWARE
CELL CULTURE AND FERMENTATION
PROCESS OPTIMIZATION
CRYOPRESERVATION
HIGH-THROUGHPUT SCREENING
MICROFLUIDICS
BIOSENSOR TECHNOLOGY
GENE THERAPY TECHNOLOGY
SINGLE-USE TOOLS
DRUG DELIVERY
BIOPROCESSING EQUIPMENT
CELL LINE DEVELOPMENT
NEXT-GENERATION SEQUENCING
BIOINFORMATICS
BIOSENSOR TECHNOLOGY
AUTOMATION AND ROBOTICS
3D BIOPRINTING
GENE EDITING
CONTINUOUS MANUFACTURING

Thought Leadership

Present Your Expertise to the Biopharma Industry's Key Stakeholders through a Variety of Available Speaking Packages.

Host a Panel Discussion

Moderate a panel discussion including one representative from your company with 3 representatives from the end user side to share views on a current industry topic

Duration: 45 minutes

Showcase Your Solutions to Educate the Market

Join in for dedicated CMO & CRO Showcases for German Market

Branding

Emphasize on your Message by Marketing and Promoting Alongside the Event

Networking & Lead Generation

Gain Exclusive Access to Contacts of High Profile Attendees through Intimate Networking Opportunities

Our Past Partners

WuXi Biologics
peli_logo_full_color-1
VectorBuilder
Tower Cold Chain
Thermo Fisher Scientific - Red BG
honeywell-Logo
Agilex Biolabs
vfv-logo
cytiva-logo-vector
Eppendorf-Logo
va-Q-tec_Logo_3c_with_Claim
Qickstat
Pfanstiehl-hd
fluid air_301_with_SSCDivision-comp289513
Korber
Aber
SGS_Logo.svg
Acro Biosystems
VWR_logo
maxcyte
sigma-aldrich
lonza
Akesa-Logo-1
BioCina_Logo
Cellvec
roquette
Almac Group
Novachem Logo 2024
Merck
IQVIA Biotech Logo Teal 1
BioOra_Brand_Main_Gradient
Sartorius Logo
fujifilm_basic (1)
BIOCYTOGEN LOGO 1
pharmadule
Copure-Filtration-Logo-002
in Vitro Technologies
Morimatsu&Pharmadule-logo
Truking logo 1
Master Control
Line Link未标题-5-02 1
and many more...
PARTNER WITH US

Sponsorship Packages

Tailored sponsorship opportunities designed to maximize your brand visibility and lead generation.

Platinum Sponsor
Enquire Platinum

Branding

  • 1 Priority positioning of corporate logo as "Platinum Sponsor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Priority positioning of corporate logo as "Platinum Sponsor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 200 words) to appear within the Official event webpage
  • 1 Priority positioning of corporate logo as "Platinum Sponsor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Brochure Distribution at the Registration Desk/Conference Table
  • 1 Distribution of corporate gifts (optional)

Onsite Benefits

  • 1 Pre-Conference Workshop (Half day) including room rental and 1 refreshment for 30 pax (limited to 1-2 Sponsors)
  • 1 20 mins presentation with 5 mins live Q&A to be presented during the main conference session
  • 1 Complimentary 20 mins end-user client case study presentation with 5 mins live Q&A to be presented during the main conference session
  • 1 Chairmanship on Conference Day 2 (optional and subject to availability)
  • 1 12sqm (6mx2m) Table Top Exhibition at Exhibition Hall (complimentary upgrade to 18sqm)
  • 1 Speaker Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 7 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 2 Exhibitor Pass to man the booth in the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors

Engagement Benefits

  • 1 Pre-event Speaker Interview to be shared with Biologics community & social media activities
  • 5 Assistance in setting up 1:1 meeting with targeted companies onsite
Gold Sponsor
Enquire Gold

Branding

  • 1 Priority positioning of corporate logo as "Gold Sponsor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Priority positioning of corporate logo as "Gold Sponsor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 150 words) to appear within the Official event webpage
  • 1 Priority positioning of corporate logo as "Gold Sponsor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Priority positioning of corporate logo as "Gold Sponsor" on conference backdrop, on-site signage, event banners and etc
  • 1 Brochure Distribution at the Registration Desk/Conference Table
  • 1 Distribution of corporate gifts (optional)

Onsite Benefits

  • 1 20 mins presentation with 5 mins live Q&A to be presented during the main conference session
  • 1 Complimentary Moderator role at panel / roundtable
  • 1 9sqm (4.5x2m) Table Top Exhibition at Exhibition Hall (complimentary upgrade to 12sqm)
  • 1 Speaker Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 6 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 2 Exhibitor Pass to man the booth in the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors

Engagement Benefits

  • 1 Pre-event Speaker Interview to be shared with Biologics community & social media activities
  • 5 Assistance in setting up 1:1 meeting with targeted companies onsite
Silver Sponsor (Enhanced)
Enquire Silver Enhanced

Branding

  • 1 Positioning of corporate logo as "Silver Sponsor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Positioning of corporate logo as "Silver Sponsor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 100 words) to appear within the Official event webpage
  • 1 Positioning of corporate logo as "Silver Sponsor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Positioning of corporate logo as "Silver Sponsor" on conference backdrop, on-site signage, event banners and etc

Onsite Benefits

  • 1 25 mins presentation with live Q&A to be presented during the main conference session
  • 1 6sqm (3x2m) Table Top Exhibition at Exhibition Hall (complimentary upgrade to 9sqm booth)
  • 1 Speaker Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 4 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 2 Exhibitor Pass to man the booth in the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors
Silver Sponsor
Enquire Silver

Branding

  • 1 Positioning of corporate logo as "Silver Sponsor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Positioning of corporate logo as "Silver Sponsor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 100 words) to appear within the Official event webpage
  • 1 Positioning of corporate logo as "Silver Sponsor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Positioning of corporate logo as "Silver Sponsor" on conference backdrop, on-site signage, event banners and etc

Onsite Benefits

  • 1 15 mins presentation with live Q&A to be presented during the main conference session
  • 1 6sqm (3x2m) Table Top Exhibition at Exhibition Hall
  • 1 Speaker Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 3 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 2 Exhibitor Pass to man the booth in the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors
Bronze Sponsor
Enquire Bronze

Branding

  • 1 Positioning of corporate logo as "Bronze Sponsor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Positioning of corporate logo as "Bronze Sponsor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 100 words) to appear within the Official event webpage
  • 1 Positioning of corporate logo as "Bronze Sponsor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Positioning of corporate logo as "Bronze Sponsor" on conference backdrop, on-site signage, event banners and etc

Onsite Benefits

  • 1 15 mins presentation with live Q&A to be presented during the main conference session
  • 1 Complimentary 1sqm space for banner display and/or small networking table at Exhibition Hall (Complimentary upgrade to 6sqm (3x2m) Table Top at Exhibition Hall for First Time Clients ONLY - one time offer)
  • 1 Speaker Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 1 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors
Exhibitor
Enquire Exhibitor

Branding

  • 1 Positioning of corporate logo as "Exhibitor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Positioning of corporate logo as "Exhibitor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 100 words) to appear within the Official event webpage
  • 1 Positioning of corporate logo as "Exhibitor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Positioning of corporate logo as "Exhibitor" on conference backdrop, on-site signage, event banners and etc

Onsite Benefits

  • 1 1-2 mins promotional video to be played during the 2 days event ad slots
  • 1 6sqm (3x2m) Table Top Exhibition at Exhibition Hall
  • 2 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 2 Exhibitor Pass to man the booth in the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors

Be a Part of This Event!

Don't miss out on unique networking, speaking and sponsorship opportunities.

Senior Portfolio Specialist
Lara Santiago
+63 9176 210686
Business Development Manager
George Gallagher
+44 204 634 8767